Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Market Cap	3.37B +144.4%
Revenue (ttm)	1.61B +47.5%
Net Income	517.39M +68.2%
EPS	22.74 -58.4%
Shares Out	22.75M
PE Ratio	6.51
Forward PE	n/a
Dividend	13.19 (9.14%)
Ex-Dividend Date	Oct 27, 2025

Volume	127,786
Average Volume	449,110
Open	147.90
Previous Close	147.90
Day's Range	141.25 - 147.70
52-Week Range	57.51 - 232.95
Beta	-0.02
RSI	43.19
Earnings Date	Feb 10, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, central nervous system, dermatological, cardiovascular diseases, vitamins and minerals, analgesics and antipyretics, respiratory system, and gastrointestinal and metabolic disorders. It also provides products for anthelmintic, anti-hypertensi...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In fiscal year 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.